XML 40 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SHARE-BASED COMPENSATION
12 Months Ended
Dec. 31, 2023
SHARE-BASED COMPENSATION  
SHARE-BASED COMPENSATION

15. SHARE-BASED COMPENSATION

Share options and restricted share units

a)2016 Global Share Incentive Plan

In January 2016, the Company’s Shareholders and Board of Directors approved 2016 Global Share Incentive Plan and amended it in March 2018 (the “Amended 2016 Plan”). Under the Amended 2016 Plan, a maximum aggregate number of 5,861,480 ordinary shares may be issued pursuant to all awards granted. Share options or restricted share unites expire 10 years from the grant date.

b)2018 Share Incentive Plan

In September 2018, the Company’s Shareholders and Board of Directors approved the 2018 Share Incentive Plan (the “2018 Plan”). Under the 2018 Plan, the maximum aggregate number of ordinary shares available for issuance is 6,733,703 ordinary shares, which shall be increased by a number equal to 1.5% of the total number of ordinary shares issued and outstanding on the last day of the immediately preceding fiscal year, each fiscal year during the term of the 2018 Plan, if determined and approved by the Board of Directors for the relevant fiscal year. The Board of Directors has approved annual increases of 2,285,407, 2,305,212 and 2,313,923 ordinary shares for the years ended December 31, 2021, 2022 and 2023, representing 1.5% of total issued and outstanding shares as of December 31, 2020, 2021 and 2022, respectively, pursuant to the 2018 Share Incentive Plan.

A summary of the share options activities under the Amended 2016 Plan and the 2018 Plan for the year ended December 31, 2023 was presented below:

     

    

Weighted

    

Weighted

    

average

remaining

Aggregate

Number of

 exercise

contractual

intrinsic 

    

shares

    

price

    

years

    

value

US$

US$

Outstanding at January 1, 2023

4,414,608

2.11

Exercised

(464,300)

0.20

Forfeited/Expired

(7,250)

0.20

Outstanding at December 31, 2023

3,943,058

2.34

4.56

1,190,466

Exercisable as of December 31, 2023

3,943,058

2.34

4.56

1,190,466

Compensation expenses recognized for share options for the years ended December 31, 2021, 2022 and 2023 were allocated to the following expense items:

 

For the Year Ended

 

December 31, 

    

2021

    

2022

    

2023

    

RMB

RMB

 

RMB

Cost of revenues

 

8,318

Selling and marketing expenses

 

2,235,102

1,936,414

905,764

Research and development expenses

 

4,018,126

3,862,189

2,191,242

General and administrative expenses

 

6,649,255

5,008,382

3,047,542

Total share options compensation expenses

 

12,910,801

10,806,985

6,144,548

No share options had been granted for the years ended December 31, 2021, 2022 and 2023. The total intrinsic value of share options exercised for the years ended December 31, 2021, 2022 and 2023, were RMB77,271,754, RMB3,708,615 and RMB4,799,425, respectively. The total fair value of shares vested for the years ended December 31, 2021, 2022 and 2023 were RMB15,732,201, RMB10,976,490 and RMB11,027,023, respectively.

As of December 31, 2023, total unrecognized compensation expense related to share options was nil.

A summary of the restricted share units activities for the year ended December 31, 2023 was presented below:

    

    

Weighted

average grant

Number of

date fair

shares

value

US$

Unvested as of January 1, 2023

 

3,890,658

4.59

Granted

 

232,000

2.31

Vested

(1,507,862)

4.44

Forfeited

(611,722)

4.30

Unvested as of December 31, 2023

 

2,003,074

4.53

The restricted share units are generally scheduled to be vested over four equal annual installments, except 128,000 restricted share units were granted in 2022 with vesting in two equal annual installments under the 2018 Plan. For the year ended December 31, 2023, 232,000 restricted share units were granted with vesting in four equal annual installments.

Compensation expenses recognized for restricted share units for the years ended December 31, 2021, 2022 and 2023 were allocated to the following expense items:

For the Year Ended

December 31, 

    

2021

    

2022

    

2023

 

RMB

RMB

RMB

Cost of revenues

 

838,515

1,224,796

1,237,902

Selling and marketing expenses

 

11,057,530

13,497,270

9,085,924

Research and development expenses

 

13,043,898

18,499,553

19,462,704

General and administrative expenses

 

9,367,412

14,190,582

11,728,226

Total restricted share units compensation expenses

 

34,307,355

47,412,201

41,514,756

As of December 31, 2023, RMB48,330,116 of total unrecognized compensation expense related to restricted share units was expected to be recognized over a weighted average period of approximately 1.92 years.

Total share-based compensation expenses recognized for the years ended December 31, 2021, 2022 and 2023 were allocated to the following expense items:

 

For the Year Ended

December 31,

 

2021

    

2022

    

2023

    

RMB

    

RMB

    

RMB

Cost of revenues

 

846,833

1,224,796

1,237,902

Selling and marketing expenses

 

13,292,632

15,433,684

9,991,688

Research and development expenses

 

17,062,024

22,361,742

21,653,946

General and administrative expenses

 

16,016,667

19,198,964

14,775,768

Total share-based compensation expense

 

47,218,156

58,219,186

47,659,304